0001628280-23-022810.txt : 20230620
0001628280-23-022810.hdr.sgml : 20230620
20230620203739
ACCESSION NUMBER: 0001628280-23-022810
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xian Ming
CENTRAL INDEX KEY: 0001743879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31573
FILM NUMBER: 231027182
MAIL ADDRESS:
STREET 1: MEDIFAST, INC.
STREET 2: 100 INTERNATIONAL DRIVE, 18TH FLOOR
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIFAST INC
CENTRAL INDEX KEY: 0000910329
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
IRS NUMBER: 133714405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11445 CRONHILL DRIVE
CITY: OWINGS MILLS
STATE: MD
ZIP: 21117
BUSINESS PHONE: 7327640619
MAIL ADDRESS:
STREET 1: 11445 CRONHILL DRIVE
CITY: OWINGS MILLS
STATE: MD
ZIP: 21117
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHRITE INC
DATE OF NAME CHANGE: 19951120
FORMER COMPANY:
FORMER CONFORMED NAME: XX
DATE OF NAME CHANGE: 19950619
FORMER COMPANY:
FORMER CONFORMED NAME: 00
DATE OF NAME CHANGE: 19950619
4
1
wk-form4_1687307849.xml
FORM 4
X0407
4
2023-06-15
0
0000910329
MEDIFAST INC
MED
0001743879
Xian Ming
C/O MEDIFAST, INC.
100 INTERNATIONAL DRIVE
BALTIMORE
MD
21202
1
0
0
0
0
Restricted Stock Units (cash settled)
2023-06-15
4
A
0
2742
0
A
Common Stock
2742
4727.834
D
Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.
/s/ Jason L. Groves attorney-in-fact
2023-06-20